Deepika Pakianathan - Insider Trading & Ownership

Entity
Individual
Location
160 Bovet Road, Suite 408, C/O Delphi Ventures, San Mateo, CA
Summary
The estimated net worth of Deepika Pakianathan is at least $440K dollars as of August 23, 2024. Deepika Pakianathan is the Director of Theravance Biopharma, Inc. and owns shares of Theravance Biopharma, Inc. (TBPH) stock worth about $410K. Deepika Pakianathan is the Director of Mereo BioPharma Group plc and owns shares of Mereo BioPharma Group plc (MREO) stock worth about $30.3K.
All Insider Reports
All Insider Reports

Ownership of Deepika Pakianathan

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TBPH Theravance Biopharma, Inc. Director $410K May 8, 2024
MREO Mereo BioPharma Group plc Director $30.3K -$466K -93.9% Aug 22, 2024
KPTI Karyopharm Therapeutics Inc. Director $0 -$1.67M -100% Jun 5, 2024
CALA Calithera Biosciences, Inc. Director Jan 27, 2023
PRDS PARDES BIOSCIENCES, INC. Director Dec 23, 2021

Insider Transactions Reported by Deepika Pakianathan:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.